Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC01432 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100507391 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEACAM21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IRF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNGB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNPO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MAGIX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNQ5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RERGL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6883 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR631 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on